A dual LC–MS (orbitrap and qQTof) metabolomics methodology has been developed for assessing the plasma rat metabolome of a metabolic syndrome model. The metabolomics methodology has been fully validated using multivariate analysis. Chronic administration of HT has been shown to produce intense metabolomics changes. The changes observed are in accordance with pharmacological data.